Home
/
Equine

Revolutionising Equine Injury Recovery

Redefining Equine
‍Recovery

Traditional methods often leave equine athletes with prolonged recovery times and increased vulnerability to recurrence. Regenall™ steps in, redefining recovery approaches and ensuring a robust future for our equine companions.
Redefining Equine Recovery
A Scientific Vision for Equine Well-being

A Scientific Vision for Equine Well-being

Regenall aims to revolutionize tendon and ligament treatment, surpassing traditional methods. Our mission is to inhibit scar tissue and promote the growth of functional tissue, paving the way for a future where technology and science redefine recovery approaches. Join us on this transformative journey.

Realizing Optimal Equine Performance

Regenall™ goes beyond treatment, offering real-time monitoring to track progress and personalize recovery plans. Witness the transformative impact on equine performance, guided by cutting-edge technology and the dedicated expertise of Regenall™
Realizing Optimal Equine Performance

Revolutionising Equine Injury Recovery

1

Before Regenall

No Improvement
Horses prior to administration of Regenall 15 months post-chronic tendon/ligament injuries showed only minimal improvement in lesion size and echogenicity of the injured tendon.
2

After Regenall

Healing
By 14 weeks the lesion size more than halved
Echogenicity
(Regeneration & Strength)
By 14 weeks the tendon had regained 80% of its normal strength
3

Continual Treatment

Prolonged Treatment
Prolonged treatment with Regenall:
  • Complete healing;
  • 100% of normal strength regained;

Pioneering Recovery: Exploring the cutting-edge tendon and ligament healing in human.

Explore the intricate phases of tendon and ligament healing, unraveling the science behind Regenall™ and its transformative impact on the body's natural repair processes.

Injury Initiation

Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.

General Case in Tendon Injury Recovery

Acute Phase (1-2 weeks):

  • Disruption of tendon tissue triggers wound repair processes, similar to skin injuries.
  • Intrinsic and extrinsic processes contribute to repair.

Case in Tendon Injury Recovery With Regenall™ Intervention

Acute Phase (1-2 weeks):

  • Regenall™ treatment moderates inflammation.
  • Aims to enhance the subsequent fibrous repair process.

Subacute Phase (Few days to months):

  • Fibroblastic response lays down fibrous scar tissue.
  • Restores mechanical strength weakened by the injury.

Subacute Phase (Few days to months):

  • Regenall™ accelerates the laying down of fibrous scar tissue.
  • Focuses on restoring mechanical strength efficiently.

Chronic Phase (Many months):

  • Scar tissue undergoes remodeling to improve functional properties.
  • Structurally strong but less functional tendon tissue may result, increasing the risk of re-injury.

Chronic Phase (Many months):

  • Regenall™ facilitates optimal remodeling of scar tissue.
  • Aims to maintain both structural strength and functionality.

Injury Initiation

Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.

General Case in Tendon Injury Recovery

Acute Phase (1-2 weeks):

  • Disruption of tendon tissue triggers wound repair processes, similar to skin injuries.
  • Intrinsic and extrinsic processes contribute to repair.

Subacute Phase (Few days to months):

  • Fibroblastic response lays down fibrous scar tissue.
  • Restores mechanical strength weakened by the injury.

Chronic Phase (Many months):

  • Scar tissue undergoes remodeling to improve functional properties.
  • Structurally strong but less functional tendon tissue may result, increasing the risk of re-injury.

Injury Initiation with Regenall

Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.

Case in Tendon Injury Recovery With Regenall™ Intervention

Acute Phase (1-2 weeks):

  • Regenall™ treatment moderates inflammation.
  • Aims to enhance the subsequent fibrous repair process.

Subacute Phase (Few days to months):

  • Regenall™ accelerates the laying down of fibrous scar tissue.
  • Focuses on restoring mechanical strength efficiently.

Chronic Phase (Many months):

  • Regenall™ facilitates optimal remodeling of scar tissue.
  • Aims to maintain both structural strength and functionality.

Scientific Validation and Study Results

A Chronological Examination of Lesion Size and Echogenicity from Injury Onset to Post-Maintenance Dose

Time of Original Injury Week
9 months prior to starting
9 months prior to starting
Lesion size = 51.6% of SOFT
Echogenicity (lesion vs healthy) = 68.1%
week 0
Week 0
Lesion size = 64.9% of cross sectional
Echogenicity (lesion vs healthy)= 68.7%

Immediately Prior to Commencing

week 3
Week 3
Lesion size = 66.5%
Echogenicity (lesion vs healthy)= 54.5%
week 5
Week 5
Lesion size = 53.8%
Echogenicity (lesion vs healthy)= 55.%
week 7
Week 7
Lesion size = 49.2%
Echogenicity (lesion vs healthy)= 65.9%
week 14
Week 14
Lesion size = 27.4%
Echogenicity (lesion vs healthy)= 76.4%

After Maintenance Dose

why us?

Results

HEALING:

Lesion size is more than halved with Regenall™.

STRENGTH:

Regenall™ indicates an improvement in strength up to a mean of 80%

CLEAR IMPACT:

Placebo horses with pre-existing injuries show no improvement.

PROLONGED TREATMENT:

Complete healing, with 100% of normal strength regained.
Quote

Regenall prolongs the active lifetime of any individual, no matter the intensity of lifestyle

let's talk

Have any questions?

Have you experienced tendon or ligament injuries in yourself or your horse? Let's discuss.

Thank you! We will reach out soon!
Oops! Something went wrong while submitting the form.
Elevating Equine and Human Tendon and
Ligament Care to New Heights
COPYRIGHT © 2024 — REGENALL